SHARES PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced a dramatic drop today following the unexpected termination of its partnership with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending its stock price plummeting by nearly 10%. The reason for the collapse of the partnership remains unclear, but industry analysts speculate that it could be